open access

Vol 85, No 3 (2014)
ARTICLES
Get Citation

Severe hemolytic disease of the newborn as a result of late and undiagnosed alloimmunization – case report

Agnieszka Drozdowska-Szymczak, Natalia Czaplińska, Beata Borek-Dzięcioł, Bożena Kociszewska-Najman, Robert Bartkowiak, Mirosław Wielgoś
DOI: 10.17772/gp/1718
·
Ginekol Pol 2014;85(3).

open access

Vol 85, No 3 (2014)
ARTICLES

Abstract

We report a case of a hemolytic disease in a newborn from the first pregnancy due to anti-D antibodies. The maternal blood group was A Rhesus negative. She had an antibody screening test twice during the pregnancy (in the second trimester) and it was negative. The pregnancy was uneventful, without any invasive procedures and bleeding. The infant was born at 39 weeks of gestation in good overall condition. After the delivery, the blood group of the neonate was indicated – A Rhesus positive, BOC positive. Anti-D antibodies were detected in maternal blood. Neonatal blood tests revealed severe anemia (hemoglobin level: 6.0 g/dl, hematocrit: 22.2%, erythrocytes: 2.01 T/L). During the first day of neonatal life, the newborn received two transfusions of red blood cells. Bilirubin level and rate of rise were not recommendation enough for exchange transfusion. The newborn was treated with continuous phototherapy since the delivery. The perinatal period was complicated with intrauterine infection and respiratory failure. Hematopoietic vitamins and iron supplementation was initiated in the second week of neonatal life due to persistent anemia. The child remained under medical care of a hematologic clinic and received human recombinant erythropoietin treatment.

Abstract

We report a case of a hemolytic disease in a newborn from the first pregnancy due to anti-D antibodies. The maternal blood group was A Rhesus negative. She had an antibody screening test twice during the pregnancy (in the second trimester) and it was negative. The pregnancy was uneventful, without any invasive procedures and bleeding. The infant was born at 39 weeks of gestation in good overall condition. After the delivery, the blood group of the neonate was indicated – A Rhesus positive, BOC positive. Anti-D antibodies were detected in maternal blood. Neonatal blood tests revealed severe anemia (hemoglobin level: 6.0 g/dl, hematocrit: 22.2%, erythrocytes: 2.01 T/L). During the first day of neonatal life, the newborn received two transfusions of red blood cells. Bilirubin level and rate of rise were not recommendation enough for exchange transfusion. The newborn was treated with continuous phototherapy since the delivery. The perinatal period was complicated with intrauterine infection and respiratory failure. Hematopoietic vitamins and iron supplementation was initiated in the second week of neonatal life due to persistent anemia. The child remained under medical care of a hematologic clinic and received human recombinant erythropoietin treatment.
Get Citation

Keywords

anemia, neonate, hemolytic disease, Anaemia

About this article
Title

Severe hemolytic disease of the newborn as a result of late and undiagnosed alloimmunization – case report

Journal

Ginekologia Polska

Issue

Vol 85, No 3 (2014)

Page views

1060

Article views/downloads

10498

DOI

10.17772/gp/1718

Bibliographic record

Ginekol Pol 2014;85(3).

Keywords

anemia
neonate
hemolytic disease
Anaemia

Authors

Agnieszka Drozdowska-Szymczak
Natalia Czaplińska
Beata Borek-Dzięcioł
Bożena Kociszewska-Najman
Robert Bartkowiak
Mirosław Wielgoś

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl